Post-Treatment Controllers: Role in HIV “Cure” Research Leslie R. CockerhamHiroyu HatanoSteven G. Deeks HIV Pathogenesis and Treatment (AL Landay, Section Editor) 19 January 2016 Pages: 1 - 9
Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection Michael L. FreemanMichael M. LedermanSara Gianella HIV Pathogenesis and Treatment (AL Landay, Section Editor) 26 January 2016 Pages: 10 - 19
Fat Matters: Understanding the Role of Adipose Tissue in Health in HIV Infection Kristine M. ErlandsonJordan E. Lake HIV Pathogenesis and Treatment (AL Landay, Section Editor) 30 January 2016 Pages: 20 - 30
Broadly Neutralizing Antibodies for HIV Eradication Kathryn E. StephensonDan H. Barouch HIV Pathogenesis and Treatment (AL Landay, Section Editor) Open access 03 February 2016 Pages: 31 - 37
Novel Imaging Methods for Analysis of Tissue Resident Cells in HIV/SIV Eirini MoysiJacob D. EstesConstantinos Petrovas HIV Pathogenesis and Treatment (AL Landay, Section Editor) 30 January 2016 Pages: 38 - 43
Recent Insights Into Cardiovascular Disease (CVD) Risk Among HIV-Infected Adults Robert C. KaplanDavid B. HannaJorge R. Kizer HIV Pathogenesis and Treatment (AL Landay, Section Editor) 24 February 2016 Pages: 44 - 52
Friend or Foe: Innate Sensing of HIV in the Female Reproductive Tract Nadia R. RoanMartin R. Jakobsen HIV Pathogenesis and Treatment (AL Landay, Section Editor) 15 February 2016 Pages: 53 - 63
Modeling and Cost-Effectiveness in HIV Prevention Margo M. JacobsenRochelle P. Walensky The Science of Prevention (JD Stekler and J Baeten, Section Editors) 30 January 2016 Pages: 64 - 75